EUVIMEDOpdag EUVIMED
Übersichtsarbeit

Gadolinium‐based contrast media does not improve the staging of neuroblastoma image‐defined risk factors at diagnosis

Cara E Morin, Reem Hasweh iD, Chris Anton, Jonathan R Dillman, Emily Orscheln, Ethan A Smith, Meera Kotagal, Brian D Weiss iD, Jiarong Ouyang, Bin Zhang, Andrew T Trout iD, Alexander J Towbin iD

Pediatric Blood & Cancer · 2024

DOI: 10.1002/pbc.30724 ↗

At a glance

Übersichtsarbeit in Pediatric Blood & Cancer, 2024. Written by Cara E Morin and 11 co-authors. Institution: Department of Radiology, Cincinnati Children's Hospital and University of Cincinnati College of Medicine, Cincinnati, Ohio, USA. Major MEDLINE topics: Contrast Media, Neuroblastoma. Cited 8 times so far (Crossref); 41 references.

AbstractSubjectsBibliografiske oplysningerCiteRelated studies

Abstract (original language)

Background

Neuroblastoma risk stratification relies on prognostic risk factors and image‐defined risk factors (IDRFs). Evaluating neuroblastoma typically involves magnetic resonance imaging (MRI) with gadolinium‐based contrast media (GBCM, “contrast”). However, there are concerns regarding adverse effects and cost of GBCM. We aimed to assess the impact of intravenous GBCM on interobserver agreement for neuroblastoma staging on baseline MRI. Procedure We reviewed baseline MRI scans of 50 children with abdominopelvic neuroblastomas confirmed by histopathology. Duplicate sets of images were created, with post‐contrast T1‐weighted sequences removed from one set. Four pediatric radiologists independently analyzed the scans in a randomized manner. They recorded primary tumor size, presence of IDRFs, and metastatic lesions. Agreement among the reviewers was measured using kappa and Fleiss kappa statistics.

Results

Mean age of included children was 3.3 years (range: 0.01–14.9 years), and 20 [40%] were females. Mean tumor size was 5.7 cm in greatest axial diameter. Pre‐contrast versus post‐contrast MRI showed excellent agreement for tumor measurement. Overlapping confidence intervals (CIs) were seen in nearly all categories of interobserver agreement on the presence or absence of individual IDRFs, with agreement ranging from poor to substantial, regardless of the presence of contrast. The overall interobserver agreement on the presence of at least one IDRF was substantial with contrast (kappa = .63; 95% CI: .52–.75) and moderate without contrast (kappa = .5; 95% CI: .39–.61); although the overlapping CIs suggest a lack of meaningful difference. Similarly, interobserver agreement on the presence or absence of individual sites of metastatic disease ranged from poor to substantial. The interobserver agreement on the overall determination of presence of metastatic disease was fair with contrast (kappa = .49; 95% CI: .38–.61) and moderate without contrast (kappa = .71; 95% CI: .59–.826).

Conclusions

Contrast does not improve tumor size measurement or radiologist agreement on the presence or absence of IDRFs or metastatic disease in children with newly diagnosed neuroblastoma.

Subjects

MeSH terms (MEDLINE)

Contrast MediaNeuroblastomaChildFemaleHumansInfant, NewbornInfantChild, PreschoolAdolescentMaleGadoliniumMagnetic Resonance ImagingRisk FactorsRetrospective Studies

Author keywords

neuroblastomaradiologysurgery

Substances

Contrast MediaGadolinium

Authors and institutions

  • Department of Radiology, Cincinnati Children's Hospital and University of Cincinnati College of Medicine, Cincinnati, Ohio, USA.
  • Division of Radiology, Al-Balqa Applied University, Al-Salt, Jordan.
  • Department of Radiology, Children's Mercy Kansas City, Kansas City, Missouri, USA.
  • Department of Surgery, University of Cincinnati College of Medicine, Division of Pediatric and Thoracic Surgery, Cincinnati Children's Hospital Medical Center, Cincinnati, Ohio, USA.
  • Cancer and Blood Disease Institute, Division of Oncology, Cincinnati Children's Hospital Medical Center, Cincinnati, Ohio, USA.
  • Department of Mathematical Sciences, University of Cincinnati, Cincinnati, Ohio, USA.

ORCID profiles: Reem Hasweh, Brian D Weiss, Andrew T Trout, Alexander J Towbin

Cite

APA

Morin, C. E., Hasweh, R., Anton, C., Dillman, J. R., Orscheln, E., Smith, E. A., Kotagal, M., Weiss, B. D., Ouyang, J., Zhang, B., Trout, A. T., & Towbin, A. J. (2024). Gadolinium‐based contrast media does not improve the staging of neuroblastoma image‐defined risk factors at diagnosis. Pediatric Blood & Cancer. https://doi.org/10.1002/pbc.30724

Vancouver

Morin CE, Hasweh R, Anton C, Dillman JR, Orscheln E, Smith EA, et al. Gadolinium‐based contrast media does not improve the staging of neuroblastoma image‐defined risk factors at diagnosis. Pediatric Blood & Cancer. 2024. doi:10.1002/pbc.30724

BibTeX
@article{Morin2024,
  author = {Morin, Cara E and Hasweh, Reem and Anton, Chris and Dillman, Jonathan R and Orscheln, Emily and Smith, Ethan A and Kotagal, Meera and Weiss, Brian D and Ouyang, Jiarong and Zhang, Bin and Trout, Andrew T and Towbin, Alexander J},
  title = {Gadolinium‐based contrast media does not improve the staging of neuroblastoma image‐defined risk factors at diagnosis},
  journal = {Pediatric Blood & Cancer},
  year = {2024},
  doi = {10.1002/pbc.30724}
}
Start for free →